Perrigo Expects Trans-Atlantic Boost: Eliminating Irish Tax Debt, Importing European Brands

In investor conference presentations, CEO Kessler says “we have a very strong case that the way we filed those taxes was correctly and the assessment should be 0,” and bringing its European consumer health brands to the US is “finally starting to really happen.”

Perrigo Company PLC wants investors to look to Europe as the source of boosts for its bottom line in 2021 through both addition and subtraction.

The subtraction, says president and CEO Murray Kessler, should come in wiping out the consumer health private label and store...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Deals

Poland’s Formeds Acquired By Private Equity

 
• By 

Enterprise Investors takes 77% stake in Polish clean-label dietary supplements manufacturer Formeds.

Urgo Makes Moves In Poland And Belgium

 
• By 

French consumer health player Urgo has added to its dietary supplements offering with separate deals in Poland and Belgium.

Ceres Pharma Acquires Belgian Probiotics Player Vésale

 
• By 

Deal adds to Ceres' portfolio probiotic supplements in categories such as women's health and immunity marketed in Europe, Asia and North America.

Haleon Utilizing AI To Develop Natural CHC Products

 
• By 

Haleon is partnering with San Francisco's Brightseed to utilize its AI technology to identify bioactive compounds in plants for use in consumer health products.

More from Business

Urgo Makes Moves In Poland And Belgium

 
• By 

French consumer health player Urgo has added to its dietary supplements offering with separate deals in Poland and Belgium.

IQVIA Consumer Health: Digestive Category Driving Global OTC Market Growth

 
• By 

An increasing awareness of and interest in gut health helped the global OTC market grow by 4.6% in value terms in 2024, according to IQVIA Consumer Health.

Dermapharm Seeks To Put Stop To Spanish Slide

 
• By 

Dermapharm shakes up management of Arkopharma subsidiary in Spain with turnaround plan not showing results.